News Features The Hope Dealers: How Clinicians and New Tech Could End Unnecessary PAD Amputations L.A. McKeown December 24, 2020
News Conference News VIVA 2020 As ‘Paclitaxelgate’ Loses Steam, Experts Mull Lasting Impact for Future Trials, Practice L.A. McKeown November 27, 2020
News Daily News ‘Frailty Meter’ May Aid Treatment Decisions in Chronic Limb-Threatening Ischemia L.A. McKeown November 24, 2020
News Conference News VIVA 2020 BVS Reboot? Signs of Durability to 2 Years in Critical Limb-Threatening Ischemia L.A. McKeown November 11, 2020
News Conference News TCT 2020 Direct Temsirolimus Delivery Promising in BTK: TANGO Phase II Study Caitlin E. Cox October 18, 2020
News Conference News ESC 2020 VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban L.A. McKeown September 03, 2020
News Daily News No Long-term Mortality Risk for Paclitaxel-Based Peripheral Devices: Medicare Advantage Cohort L.A. McKeown June 29, 2020
News Conference News ACC 2020 New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy L.A. McKeown April 02, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Conference News LINC 2020 Lutonix BTK Studies: Below-the-Knee Challenges Linger L.A. McKeown January 29, 2020
News Conference News LINC 2020 COMPARE: Similar Efficacy and Safety for Paclitaxel Balloons Regardless of Dose L.A. McKeown January 28, 2020
News Conference News ISET 2020 FDA’s First Take on New Paclitaxel Concerns in CLI Caitlin E. Cox January 24, 2020
News Daily News Paclitaxel DCBs Now Implicated in Death, Amputation in Below-the-Knee CLI L.A. McKeown January 15, 2020